Cargando…
Engineering Nanoparticles for Targeted Delivery of Nucleic Acid Therapeutics in Tumor
In the past 10 years, with the increase of investment in clinical nano-gene therapy, there are many trials that have been discontinued due to poor efficacy and serious side effects. Therefore, it is particularly important to design a suitable gene delivery system. In this paper, we introduce the app...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6197778/ https://www.ncbi.nlm.nih.gov/pubmed/30364598 http://dx.doi.org/10.1016/j.omtm.2018.09.002 |
_version_ | 1783364842158030848 |
---|---|
author | Xiao, Yao Shi, Kun Qu, Ying Chu, Bingyang Qian, Zhiyong |
author_facet | Xiao, Yao Shi, Kun Qu, Ying Chu, Bingyang Qian, Zhiyong |
author_sort | Xiao, Yao |
collection | PubMed |
description | In the past 10 years, with the increase of investment in clinical nano-gene therapy, there are many trials that have been discontinued due to poor efficacy and serious side effects. Therefore, it is particularly important to design a suitable gene delivery system. In this paper, we introduce the application of liposomes, polymers, and inorganics in gene delivery; also, different modifications with some stimuli-responsive systems can effectively improve the efficiency of gene delivery and reduce cytotoxicity and other side effects. Besides, the co-delivery of chemotherapy drugs with a drug tolerance-related gene or oncogene provides a better theoretical basis for clinical cancer gene therapy. |
format | Online Article Text |
id | pubmed-6197778 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | American Society of Gene & Cell Therapy |
record_format | MEDLINE/PubMed |
spelling | pubmed-61977782018-10-24 Engineering Nanoparticles for Targeted Delivery of Nucleic Acid Therapeutics in Tumor Xiao, Yao Shi, Kun Qu, Ying Chu, Bingyang Qian, Zhiyong Mol Ther Methods Clin Dev Article In the past 10 years, with the increase of investment in clinical nano-gene therapy, there are many trials that have been discontinued due to poor efficacy and serious side effects. Therefore, it is particularly important to design a suitable gene delivery system. In this paper, we introduce the application of liposomes, polymers, and inorganics in gene delivery; also, different modifications with some stimuli-responsive systems can effectively improve the efficiency of gene delivery and reduce cytotoxicity and other side effects. Besides, the co-delivery of chemotherapy drugs with a drug tolerance-related gene or oncogene provides a better theoretical basis for clinical cancer gene therapy. American Society of Gene & Cell Therapy 2018-09-22 /pmc/articles/PMC6197778/ /pubmed/30364598 http://dx.doi.org/10.1016/j.omtm.2018.09.002 Text en © 2018 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Article Xiao, Yao Shi, Kun Qu, Ying Chu, Bingyang Qian, Zhiyong Engineering Nanoparticles for Targeted Delivery of Nucleic Acid Therapeutics in Tumor |
title | Engineering Nanoparticles for Targeted Delivery of Nucleic Acid Therapeutics in Tumor |
title_full | Engineering Nanoparticles for Targeted Delivery of Nucleic Acid Therapeutics in Tumor |
title_fullStr | Engineering Nanoparticles for Targeted Delivery of Nucleic Acid Therapeutics in Tumor |
title_full_unstemmed | Engineering Nanoparticles for Targeted Delivery of Nucleic Acid Therapeutics in Tumor |
title_short | Engineering Nanoparticles for Targeted Delivery of Nucleic Acid Therapeutics in Tumor |
title_sort | engineering nanoparticles for targeted delivery of nucleic acid therapeutics in tumor |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6197778/ https://www.ncbi.nlm.nih.gov/pubmed/30364598 http://dx.doi.org/10.1016/j.omtm.2018.09.002 |
work_keys_str_mv | AT xiaoyao engineeringnanoparticlesfortargeteddeliveryofnucleicacidtherapeuticsintumor AT shikun engineeringnanoparticlesfortargeteddeliveryofnucleicacidtherapeuticsintumor AT quying engineeringnanoparticlesfortargeteddeliveryofnucleicacidtherapeuticsintumor AT chubingyang engineeringnanoparticlesfortargeteddeliveryofnucleicacidtherapeuticsintumor AT qianzhiyong engineeringnanoparticlesfortargeteddeliveryofnucleicacidtherapeuticsintumor |